SWORD HEALTH

Virgilio Bento was a robotics and AI researcher in Portugal who noticed that physical therapy was broken. Patients had to visit clinics 2-3 times per week for weeks or months, which was expensive, inconvenient, and had terrible adherence rates (most people quit their PT exercises).

His insight was that motion-tracking AI could watch patients exercise at home and provide real-time feedback on form and technique — essentially replicating what a physical therapist does during an in-person session. He founded Sword Health in 2015 in Porto, Portugal, and developed a system that uses computer vision and motion sensors to guide patients through PT exercises at home.

The company moved its headquarters to New York and began selling to large employers and health plans.

Sword Health sells to employers and health plans (B2B). Companies pay a per-member-per-month (PMPM) fee to offer Sword as a benefit to their employees.

When an employee has musculoskeletal pain (back pain, knee pain, shoulder pain, post-surgical recovery), they enroll in a Sword program and receive a motion sensor kit. They do exercises at home while the AI system provides real-time correction and feedback.

A human physical therapist supervises remotely and adjusts the program as needed. The value proposition to employers is cost reduction — musculoskeletal issues are the #1 health cost for most employers.

Sword's Digital MSK Therapy uses motion sensors and AI to deliver personalized physical therapy at home. Their AI Clinical Assistant (Phoenix) provides real-time form correction during exercises.

A human physical therapist oversees each patient remotely. Sword Bloom focuses on women's pelvic health.

Sword Move is a preventive program for at-risk employees. The platform includes progress tracking, pain assessments, and outcome reporting for employers.

Sword grew by selling to large self-insured employers who were desperate to reduce healthcare spending. Musculoskeletal care costs US employers over $200 billion annually.

Sword's clinical studies showed 62% cost reduction and 2.4x better outcomes versus traditional PT. They expanded from MSK into women's pelvic health, chronic pain management, and preventive care.

International expansion (US, UK, Europe, Australia) broadened the market. The COVID pandemic accelerated demand for virtual healthcare solutions.

Convincing employers and insurers that AI-driven virtual PT is as effective as in-person therapy is an ongoing challenge. Clinical evidence is strong but some providers and payers remain skeptical.

Competition from Hinge Health (another virtual MSK company, valued at $6.2 billion), Kaia Health, and traditional PT chains is fierce. The regulatory environment for AI in healthcare is evolving.

Patient engagement (getting people to actually do their exercises consistently) remains difficult.

Khosla Ventures, General Atlantic, Sapphire Ventures, and Dragoneer Investment Group have invested. The company reached a $3 billion valuation.

Earlier rounds included backing from Founders Fund and BOND Capital. The European origins helped secure early contracts with European health systems before the US expansion.